FDA inspection
Scinopharm Taiwan Ltd: FDA inspection ending Apr 1, 2022
FDA inspection 1166825 · Voluntary Action Indicated (VAI) · Tainan City
Key facts
| Inspection ID | 1166825 |
|---|---|
| Firm | Scinopharm Taiwan Ltd |
| FEI number | 3002840477 |
| Address | Shan-Hua, No. 1 Nanke 8th Rd.; Shanhua Dist. |
| City | Tainan City |
| Fiscal year | 2022 |
| Inspection end date | Apr 1, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data